Bioaccumulations of aluminum and the effects of chelating agents on different organs of Cirrhinus mrigala
Graphical abstract
Highlights
► ICP-AES determines the aluminum toxicity induced changes in muscle, gill, kidney, brain liver, tissue. ► ICP-AES findings the aluminum accumulation, recovery, uptake rate, excretion rate and biological magnification factors. ► Results of the ICP-AES study were found to be in agreement with the aluminum accumulation patterns that follow the order: muscle > gill > kidney > brain > liver in Cirrhinus mrigala fingerlings.
Introduction
Aluminum is the most abundant metal and comprises about 8% of the Earth's crust and it is found in combination with oxygen, silicon, fluorine and other elements in soil, rocks, clays and gems (Sigel and Sigel, 1988) although it has no known biological function (Farina et al., 2002). Presently, aluminum utensils are widely used throughout the world, especially in developing countries (Lin et al., 1997). The use of such tools may increase an individual's aluminum exposure, particularly when these are used with salty, acidic or alkaline foods (Sharma and Mishra, 2006). Additionally, aluminum and its salts are commonly used in daily life as it they are perceived to be non-toxic and quickly excreted by urine. However, this element can have negative impact human and animal health (Osinska et al., 2004). Aluminum is potentially toxic to humans and the Agency for Toxic Substances and Disease Registry (ATSDR) (Agency for Toxic, 2008), reported that aluminum is distributed mainly in the bone, liver, testis, kidneys and brain. In patients on dialysis (Alfrey et al., 1976) or on long-term total parenteral nutrition (Klein, 1993), this metal accumulates in different organs. The toxicological effects of aluminum in human include encephalopathy (Ward et al., 1978) bone disease, anemia and skeletal system disease (Short et al., 1980). Furthermore, aluminum is possibly a contributing factor in the development of Alzheimer's disease (Gupta et al., 2005). However, this remains controversial (Campbell, 2002, Flaten, 2001).
Chelating agents possess the common ability to form complexes with heavy metals and thereby prevent or reverse the binding of metallic captions to body legends. Chelating therapy is recommended for heavy metal poisoning and these metals exert their toxic effects by combining with one or more reactive groups essential for normal physiological functions. Deferroxamine (DFO) and deferiprone (DFP) chelating agents are designed specifically to compete with these groups for the metals and thereby prevent or reverse toxic effects and enhance the excretion of metals. DFO is the principal product of the various side amines obtained from Streptomyces pilosus (Keberle, 1964). In the present study Cirrhinus mrigala fish was selected for experimental investigation because it is highly sensitive to various toxicants, as well as being a perennially abundant, fast breeding fish, which tolerates a wide range of water quality parameters and temperatures. These fish are also commercially and nutritionally important.
Inductively couple plasma atomic emission spectroscopy (ICP-AES) as employed in this report, is an important technique to study the trace elements at molecular level in various biological samples. It is particularly effective in this context due to its high sensitivity for detecting the major trace elements (Karl and Peter, 1995).
Section snippets
Chemicals
All the chemicals aluminum sulfate (Al2(SO4)3), deferroxamine (DFO) and deferiprone (DFP) were purchased from S.D. Fine, Novartis and Sigma Aldrich, chemicals limited, Mumbai, India.
Experimental design
Test specimens were divided in to eleven groups; each consisted of 20 fish and were reserved in 20 l glass trough equipped with continuous air supply. The test water was changed daily at 8 a.m. morning by slowly siphoning of water from each container along with the waste fed and fecal material that were from Annamalai
Muscle
In the present study gave us Muscle tissues accumulates aluminum as 142.62 μg/g in acute exposure and 45.33 μg/g, 50.21 μg/g, 73.22 μg/g and 159.25 μg/g in chronic exposure at 15, 30, 60 and 90 days, respectively as shown in Table 1. Then treatment with chelating agents DFO and DFP reduced the concentration of aluminum in the muscle to significantly 73% and 71% for acute, 56–71% and 50–70% for chronic exposure, respectively. Bioaccumulation and elimination of aluminum in muscles during acute and
Conclusion
The present study indicates that the aluminum accumulation pattern follows the order: muscle > gill > kidney > brain > liver by using ICP-AES. Chelating agents were most versatile and effective antidotes for metals intoxication and stable complexes, which can effectively accumulate in organisms, thereby reducing the toxicity of the metals to organisms. The present study suggests that ICP-AES is best instrument to find out the aluminum accumulation in various organs of C. mirgala and DFO and DFP are the
Conflict of interest
The authors declare that there are no conflicts of interest.
Acknowledgement
The authors are thankful and grateful to Dr. AN. Kannappan, Professor, Dean and Head, Department of Physics, Annamalai University, Tamilnadu-608002, for providing all necessary facilities to carry out the present work successfully.
References (28)
- et al.
Effects of aluminium sulfate on erythropoiesis in rats
Toxicol. Lett.
(2002) Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water
Brain Res. Bull.
(2001)- et al.
Amelioration of fumonisin B1 hepatotoxicity in mice by depletion of T cells with anti-Thy-1.2
Reprod. Toxicol.
(2006) - et al.
Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminium
Lancet
(1978) Toxicological profile for Aluminium
(2008)- et al.
Bioavailability and toxicity of freshly cray fish pacifastaacus leniusculus
- et al.
The dialysis encephalopathy syndrome. Possible aluminium intoxication
N. Engl. J. Med.
(1976) - et al.
Introduction of hypochromic macrocytic aneamia in Oreochromis hybrid (Cichlid), exposed to 100 mg/L (sub-lethal dose) of aluminium
Sci. Technol. Res. J.
(2000) Pollution due to heavy metals and their compounds
The potential role of aluminium in Alzheimer's disease
Nephrol. Dial. Transplant.
(2002)